Cadrenal Therapeutics, Inc. · NASDAQ:CVKD

Pham Quang X sold 4,126 Cadrenal Therapeutics, Inc. shares (Form 4)

Traded Jun 16 to Jun 17, 2026 · Filed Jun 18, 2026

From Jun 16 to Jun 17, 2026, Pham Quang X (Director, Chairman, CEO and Interim CFO, 10% owner) sold 4,126 Cadrenal Therapeutics, Inc. shares at an average US$3.18 for US$13,110 under a trading plan, leaving 128,589 shares. Filed Jun 18, 2026 (Form 4).

Sold
4,126 shares
Price
US$3.18 average (US$3.16 to US$3.18)
Value
US$13,110
Holding after
128,589 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairman, CEO and Interim CFO, 10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 16, 2026Common StockSale3,613US$3.18129,102Direct
Jun 17, 2026Common StockSale513US$3.16128,589Direct

Source

View original at SEC

Related